This publication explains some of the ideas and science behind HIV and treatment.  Each section includes a picture and summary notes. Additional text in each section tells a more detailed story. The resource was developed as an advocacy course for HIV positive people. Nearly everyone who is HIV positive has ...

29 June 2017 — Geneva, Switzerland — ICASO’s Executive Director, Mary Ann Torres, representing the organization at the 40th meeting of the UNAIDS Programme Coordinating Board, made an intervention during the thematic segment, entitled “HIV Prevention 2020: A Global Partnership for Delivery.”  Mary Ann’s remarks, ...

Rapid risk assessment: Hepatitis A outbreak in the EU/EEA mostly affecting men who have sex with men, 3rd update, 28 June 2017 Since June 2016, 1 500 confirmed hepatitis A (HAV) cases and 2 660 probable or suspected cases have been reported in the EU, predominantly ...

Individuals and organizations interested in signing on to a civil society version of the Moscow Declaration that could serve as a blueprint for commitments and action toward ending the global impacts of tuberculosis over the next decade and a half have one more day to ...

Six case studies documented by the Eurasian Coalition on Male Health Global Fund policies on the composition of country coordinating mechanisms (CCMs) have resulted in increased participation of LGBT organizations on CCMs in Eastern Europe and Central Asia (EECA). It has also resulted in greater participation ...

As the government prepares to take on more financial responsibility, the country still faces challenges because of ongoing conflict Ukraine has submitted a TB/HIV funding request worth $119.5 million that the country expects will help broaden services, especially among key populations. The proposal includes a further ...

At its June meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for approval a generic version of Atripla – Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan (efavirenz/emtricitabine/tenofovir disoproxil) for the treatment of HIV infection. Summary of opinion for Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan is available here. [gview ...

The Global Fund to Fight AIDS, Tuberculosis and Malaria is a major financier of national HIV responses and a vital source of prevention investments. By 2015, the Global Fund supported 3.6 million pregnant women to receive ARV prophylaxis to prevent transmission to their unborn children ...

Countries in Western and Southern Europe are well on their way to meeting the UNAIDS 90-90-90 targets, according to a study published in Clinical Infectious Diseases. Using data collected to the end of 2013, a survey of eleven countries shows that an estimated 84% of people ...

Key HIV drugs added to the list of medicines critical to public health, including tenofovir for HIV prevention, and dolutegravir. Earlier this month, the World Health Organization (WHO) updated their list of medicines deemed ‘essential’ as part of a well-functioning health system. That is, the drugs ...

Indian scientists from the University of Delhi have identified molecules that could effectively inhibit TB virus and have published all the results of the study in Scientific Reports journal. The molecules are targeting a gene, important for  the bacterium’s survival. Possibly they may find a new ...

Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response. People who inject drugs (PWID) are historically viewed as having “difficult to treat” hepatitis C disease, ...

Hepatitis and other drug-related infectious diseases will be the focus of ‘Hepatitis week’, taking place at the EU drugs agency (EMCDDA) in Lisbon from 12–16 June 2017. The initiative will bring together some 100 specialists from: EU Member States, candidate and potential candidate countries to ...

Today we begin the launch of “Ten years in public health 2007-2017” – a report that chronicles the evolution of global public health over the decade that I have served as Director-General at WHO. This series of chapters, which will be published over the next 6 ...

On 8 June 2017, Alliance for Public Health (Alliance) hosted a meeting with representatives of the WHO assessment mission on viral hepatitis, attended by representatives of Alliance, the Ministry of Health of Ukraine, the Public Health Center of the Ministry of Health, and the US ...

Austerity, international donor retreat and poor political support are severely limiting harm reduction responses in several European Union (EU) countries. A report by Harm Reduction International (HRI) and the Eurasian Harm Reduction Network (EHRN) finds harm reduction funding to be “in crisis” in Bulgaria, Romania, Poland, ...

This information note is an update of the alert prepared by ICASO in 2015 to provide advice to civil society and community groups on how to engage in grant-making activities once a funding request has been developed. Following the submission of a funding request to ...

All Member States of the United Nations adopted the 2030 Agenda for Sustainable Development and its 17 Sustainable Development Goals (SDGs) in 2015. Now, countries are engaged in adapting this framework to their national contexts and the specific realities they face at the country level. In ...